Campbell & Co Investment Adviser’s Genesco GCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$733K Buy
21,720
+4,386
+25% +$154K 0.04% 653
2026
Q1
$503K Buy
+17,334
New +$498K 0.03% 751
2025
Q4
Sell
-14,888
Closed -$432K 1232
2025
Q3
$432K Buy
14,888
+3,959
+36% +$109K 0.03% 790
2025
Q2
$215K Sell
10,929
-22,765
-68% -$476K 0.01% 1045
2025
Q1
$715K Buy
+33,694
New +$1.17M 0.05% 543
2022
Q4
Sell
-15,522
Closed -$610K 854
2022
Q3
$610K Buy
15,522
+7,709
+99% +$412K 0.14% 254
2022
Q2
$390K Buy
+7,813
New +$468K 0.11% 365
2021
Q1
Sell
-7,146
Closed -$215K 492
2020
Q4
$215K Buy
+7,146
New +$183K 0.13% 344
2020
Q1
Sell
-14,657
Closed -$702K 211
2019
Q4
$702K Sell
14,657
-2,799
-16% -$116K 0.22% 125
2019
Q3
$699K Buy
+17,456
New +$674K 0.26% 88
2017
Q3
Sell
-7,401
Closed -$251K 393
2017
Q2
$251K Buy
+7,401
New +$330K 0.23% 194
2015
Q3
Sell
-5,398
Closed -$356K 349
2015
Q2
$356K Buy
+5,398
New +$370K 0.3% 108

Other funds holding GCO

Campbell & Co Investment Adviser's GCO Position: Q2 2026 in Review

Campbell & Co Investment Adviser increased its Genesco (GCO) stake by 25% in Q2 2026, buying an estimated $154K and bringing the position to 21,720 shares worth $733K. The position accounts for 0.04% of the portfolio, ranked #653.

Campbell & Co Investment Adviser first reported a position in GCO in Q2 2015 and has held it in 12 quarters since. 26 funds tracked by Wall St. Rank hold GCO as of Q2 2026.

  • Campbell & Co Investment Adviser held 21,720 shares of Genesco worth $733K as of Q2 2026.
  • Campbell & Co Investment Adviser bought 4,386 Genesco shares in Q2 2026, an estimated $154K.
  • Genesco made up 0.04% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #653 holding.
  • Campbell & Co Investment Adviser first reported a position in Genesco in Q2 2015 and has held it in 12 quarters since.
  • 26 funds tracked by Wall St. Rank held Genesco as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.